相关实验视频
Updated: Jun 25, 2025

07:20
Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
9.9K
近视控制的局部亚热素:一篇评论
1Medical Center, Eye Center, University Freiburg, Germany.
概括
局部使用的阿特罗平有效地预防儿童近视,有效性和副作用取决于剂量. 新的研究研究了其在不同人群中的使用和初级预防策略.
科学领域:
- 眼科医生 眼科 眼科
- 儿科眼科护理 儿科眼科护理
- 控制近视,控制近视.
背景情况:
- 形眼滴是一种经过验证的干预措施,可以减缓儿童近视的进展.
- 以前的研究,主要是来自亚洲人群的研究,证实了阿特罗宾的安全性和有效性.
- 热素度与治疗效果和不良事件之间存在剂量依赖的关系.
研究的目的:
- 审查近期关于白人占主导地位的人群中对近视控制的氨酸的最新数据.
- 调查阿特罗宾的疗效和副作用概况的潜在种族依赖的变化.
- 探索氨酸在新发近视的初级预防中的作用.
主要方法:
- 对最近的临床试验和观察性研究进行系统审查.
- 根据种族和氨酸剂量分层分析的数据.
- 对专注于预防近视事件的研究进行评估.
主要成果:
- 氨酸的有效性和耐受性在不同族群之间有所不同.
- 较低的阿特罗宾度可能会在疗效和副作用之间提供有利的平衡.
- 有证据表明,氨酸在预防近视发作,而不仅仅是进展方面具有潜力.
结论:
- 阿特罗平仍然是儿童近视管理的关键策略.
- 需要进一步的研究,以优化在不同人群中使用氨酸.
- 考虑到种族和剂量的个性化方法对于有效的近视预防至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
430
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
430
Cholinergic Antagonists: Pharmacokinetics
433
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
433
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731
Angle Closure Glaucoma: Treatment
479
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
479
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K

